Patricia Eifel, M.D., FASTRO, a radiation oncologist at M.D. Anderson Cancer Center in Houston and chairman of ASTRO.


September 2, 2009 - ASTRO, the American Society for Radiation Oncology, submitted official comments to the Centers for Medicare and Medicaid Services (CMS) asking it to stop its proposed changes to the Medicare policies and payment rates for physician services, including radiation oncology, that would cut radiation therapy services by nearly 20 percent.

In response to the July 13 Medicare physician fee schedule proposed rule, ASTRO wrote CMS urging it to withdraw its proposal to increase the equipment utilization rate for radiation therapy. ASTRO also asked CMS to delay implementation of new physician practice information survey data pending a review of the information and ASTRO‚s concerns. 

New technology and improved techniques have allowed radiation oncologists to dramatically improve how they target radiation to more effectively eliminate cancer cells while protecting healthy tissue. This has allowed radiation oncologists to improve cure rates while decreasing painful side effects, allowing patients to not only survive, but thrive after their cancer treatments.

While CMS projects the overall impact of the payment reductions to be 19 percent, the rates for certain needed cancer services would be reduced by up to 44 percent. An ASTRO survey conducted in July found that cuts of this scale would have a particularly devastating effect on freestanding and community-based cancer centers, causing many to close, stop accepting Medicare patients and reduce critical services to cancer patients.

The extreme cuts are due in part to CMS increasing the utilization rate for equipment costing more than $1 million from 50 to 90 percent. By increasing the utilization rate, the payment for each service is reduced significantly. CMS did not reference any actual data for radiation therapy equipment in proposing to increase the rate to 90 percent, basing its proposed change on expanding a Medicare Payment Advisory Commission (MedPAC) recommendation focused on diagnostic imaging equipment. In its official comments on Medicare's proposal (available at www.medpac.gov) August 31, 2009, MedPAC said it "did not contemplate" applying its recommendation to increase the equipment utilization rate to radiation therapy machines.

ASTRO also told CMS there are problems with the agency's method for calculating practice expenses, issues with the proposed changes in malpractice RVUs, an inappropriate proposal to eliminate consultation codes, and a need for significant adjustments to the physician practice information survey data for radiation oncology. ASTRO provided CMS a detailed analysis showing that PPIS data for radiation oncology was improperly weighted and distorted. 

"We believe we have identified several areas for CMS to explore as it finalizes the proposed rule for physician services. We hope the agency will consider these recommendations for the sake of the hundreds of thousands of cancer patients we serve each year," said Patricia Eifel, M.D., FASTRO, a radiation oncologist at M.D. Anderson Cancer Center in Houston and chairman of ASTRO.

Also today, Reps. Lois Capps (D-Calif.), Sue Myrick (R-N.C.), Mike Rogers (R-Mich.) and Parker Griffith (D-Ala.) and 59 other House members sent a letter to Health and Human Services Secretary Kathleen Sebelius asking her to reconsider the proposed cuts. A similar letter is circulating in the Senate, with 10 senators already committed to sign on to a letter led by Sens. Blanche Lincoln (D-Ark.) and Richard Burr (R-N.C.). ASTRO applauds the commitment and leadership of these lawmakers for protecting cancer patient access to radiation therapy.

The House letter and the entire 26-page ASTRO comment letter with attachments can be found at www.astro.org/medicarecuts.

For more information: www.rtanswers.org


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now